-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Axogen, Raises Price Target to $42

Benzinga·02/24/2026 14:35:46
Listen to the news
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $34 to $42.